What Is Topiramate?

Topiramate is an anticonvulsant medication originally developed for epilepsy that's also FDA-approved for migraine prevention. It works through multiple mechanisms in the brain and may help with certain other pain conditions. Brand names include Topamax and Trokendi XR.1

How It Works2

  • Multiple mechanisms of action
  • Enhances GABA activity
  • Blocks sodium channels
  • Reduces glutamate activity
  • Weak carbonic anhydrase inhibitor

Approved Uses

  • Epilepsy
  • Migraine prevention

Off-Label Pain Uses

  • Chronic daily headache
  • Cluster headache (sometimes)
  • Neuropathic pain
  • Fibromyalgia (mixed evidence)

Dosing3

  • Start very low (25 mg/day)
  • Increase slowly over weeks
  • Target dose varies by condition
  • Migraine: often 50-100 mg/day
  • Slow titration reduces side effects

Common Side Effects

  • Cognitive effects ("foggy thinking")
  • Word-finding difficulty
  • Tingling in hands/feet
  • Fatigue
  • Nausea
  • Taste changes
  • Weight loss (can be benefit or problem)
  • Appetite suppression

Serious Risks

  • Kidney stones
  • Metabolic acidosis
  • Acute glaucoma (rare emergency)
  • Overheating (reduced sweating)
  • Birth defects (avoid in pregnancy)
  • Suicidal thoughts (rare)

Important Precautions

  • Stay well hydrated (prevents stones)
  • Effective birth control essential
  • Avoid in liver/kidney disease
  • Can interact with birth control pills
  • Monitor for eye problems

Who Might Consider

  • Frequent migraines needing prevention
  • Especially if weight loss desired
  • Failed other preventives
  • Co-existing epilepsy

Who Should Avoid

  • Pregnant or planning pregnancy
  • History of kidney stones
  • Glaucoma
  • Cognitive jobs requiring word fluency

References

  1. Silberstein SD, Neto W, Schmitt J, Jacobs D. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol. 2004;61(4):490-495.
  2. Shank RP, Gardocki JF, Streeter AJ, Maryanoff BE. An overview of the preclinical aspects of topiramate. Epilepsia. 2000;41(Suppl 1):S3-9.
  3. Bussone G, Diener HC, Pfeil J, Schwalen S. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials. Int J Clin Pract. 2005;59(8):961-968.